Analyzing array data using supervised methods

Pharmacogenomics

Volumn 3, Issue 3, 2002, Pages 403-415

  Ringnér, Markus ^a   Peterson, Carsten ^a   Khan, Javed ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Artificial neural networks; Bioinformatics; Diagnostic classification; Diagnostic prediction; DNA chip; Drug targets; Genes; Machine learning; Microarray; Support vector machines; Target identification

Indexed keywords

ARTICLE; ARTIFICIAL NEURAL NETWORK; CALCULATION; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DNA MICROARRAY; DRUG MECHANISM; GENE CLUSTER; GENE EXPRESSION; GENE TARGETING; GENE TECHNOLOGY; GENETIC TOXICOLOGY; GENOME ANALYSIS; HUMAN; INFORMATION PROCESSING; LABORATORY AUTOMATION; METHODOLOGY; PHARMACOGENOMICS;

ARTIFICIAL INTELLIGENCE; DATA INTERPRETATION, STATISTICAL; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS;

EID: 0036262111     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.3.3.403     Document Type: Article

References (55)

1. Initial sequencing and analysis of the human genome
2. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
3. Expression monitoring by hybridization to high-density oligonucleotide arrays
4. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer
5. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
6. Expression profiling using cDNA microarrays
7. DNA microarray technology: The anticipated impact on the study of human disease
8. Applications of biochip and microarray systems in pharmacogenomics
9. Computational analysis of microarray data
10. Drug target validation and identification of secondary drug target effects using DNA microarrays
11. Ratio statistics of gene expression levels and applications to microarray data analysis
12. Missing value estimation methods for DNA microarrays
13. Testing for differentially-expressed genes by maximum-likelihood analysis of microarray data
14. Bootstrapping cluster analysis: Assessing the reliability of conclusions from microarray experiments
15. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
16. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
17. Molecular portraits of human breast tumours
18. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays
19. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
20. Diversity of gene expression in adenocarcinoma of the lung
21. Cluster analysis and display of genome-wide expression patterns
22. Systematic determination of genetic network architecture
23. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
24. Molecular classification of cutaneous malignant melanoma by gene expression profiling
25. Prediction of central nervous system embryonal tumour outcome based on gene expression
26. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
27. Comparison of discrimination methods for the classification of tumors using gene expression data
28. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
29. Gene-expression profiles in hereditary breast cancer
30. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles
31. Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile
32. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
33. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
34. Gene expression profiling predicts clinical outcome of breast cancer
35. Tissue classification with gene expression profiles
36. Scoring genes for relevance
37. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling
38. Feature (gene) selection in gene expression-based tumor classification
39. Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes
40. An introduction to support vector machines: And other kernel-based learning methods
41. Neural networks for pattern recognition
42. Knowledge-based analysis of microarray gene expression data by using support vector machines
43. Support vector machine classification and validation of cancer tissue samples using microarray expression data
44. Multiclass cancer diagnosis using tumor gene expression signatures
45. Molecular classification of human carcinomas by use of gene expression signatures
46. Predictive non-linear modeling of complex data by artificial neural networks
47. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
48. Genome-wide analysis of DNA copy- number changes using cDNA microarrays
49. Detection of gene amplification by genomic hybridization to cDNA microarrays
50. The HER-2/neu oncogene: Prognostic factor, predictive factor and target for therapy
51. The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia
52. Microarrays of cells expressing defined cDNAs
53. A gene expression database for the molecular pharmacology of cancer
54. Chemosensitivity prediction by transcriptional profiling
55. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs